Department of Public Health and Sport Science, Children's Health & Exercise Research Centre (CHERC), Faculty of Health and Life Sciences University of Exeter United Kingdom.
Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences University of Exeter United Kingdom.
J Am Heart Assoc. 2024 Sep 3;13(17):e034035. doi: 10.1161/JAHA.123.034035. Epub 2024 Aug 27.
Peak oxygen consumption (peak ) is routinely measured in people who have congenital heart disease and is reported as a percentage of predicted value, based upon age- and sex-matched normative reference values (NRVs). This study aimed to identify which NRVs are being used, assess whether NRVs are being applied appropriately, and evaluate if recommended NRVs are valid when applied to people with congenital heart disease.
A systematic scoping review identified studies that reported peak percentage of predicted value in people with congenital heart disease. A modified risk of bias tool evaluated the included studies. Forty-five studies reported peak percentage of predicted value, and only 21 (47%) studies described or provided a reference on how their percentage of predicted value was calculated. The most cited NRVs were from Wasserman (n=12) and Cooper and Weiler-Ravell (n=7). Risk of bias analysis judged 63% of studies as having some concerns. The NRVs recommended by the American Heart Association were applied to participants with a Fontan circulation (n=70; aged 26.5±6.4 years; 59% women) to examine validity. Predicted peak values from the Wasserman NRV was not significantly associated to measured peak values (men: b=0.31, ≤0.01; women: b=0.07, =0.02).
Numerous NRVs have been applied to individuals with congenital heart disease and are often poorly reported and inappropriately matched to participants. The Wasserman NRV was the most cited but showed poor validity when applied to a Fontan cohort.
在患有先天性心脏病的人群中, routinely measured (常规测量)峰值耗氧量(peak ),并报告为与年龄和性别匹配的正常参考值(NRVs)的百分比。本研究旨在确定正在使用哪些 NRVs,评估 NRVs 是否被适当地应用,以及评估当应用于患有先天性心脏病的人群时, recommended NRVs 是否有效。
一项系统的范围综述确定了报道了先天性心脏病患者 peak 百分比预测值的研究。一项改良的偏倚风险工具评估了纳入的研究。45 项研究报告了 peak 百分比预测值,但只有 21 项(47%)研究描述或提供了其百分比预测值的计算方法。引用最多的 NRVs 来自 Wasserman(n=12)和 Cooper 和 Weiler-Ravell(n=7)。偏倚风险分析判断 63%的研究存在一些问题。美国心脏协会推荐的 NRVs 被应用于具有 Fontan 循环的参与者(n=70;年龄 26.5±6.4 岁;59%为女性),以检查有效性。Wasserman NRV 预测的 peak 值与测量的 peak 值无显著相关性(男性:b=0.31,≤0.01;女性:b=0.07,=0.02)。
许多 NRVs 已应用于先天性心脏病患者,但往往报告不佳,且与参与者的匹配不恰当。Wasserman NRV 被引用最多,但在应用于 Fontan 队列时显示出较差的有效性。